Think

Search This Blog

New Drug Approved for Early Alzheimer’s

July 02, 2024

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

Pam Belluck | NYTimes Health | Disclosure

Get link
Facebook
Twitter
Pinterest
Email
Other Apps

Comments

Missouri Reports Bird Flu in a Patient Without a Known Risk

Previous human infections occurred in workers on farms. But community transmission of the virus remains unlikely for now, experts said. Apoorva Mandavilli | NYTimes Health | Disclosure

Research That Led to Obesity Drugs Wins Major Medical Prize

Three scientists were recognized by the Lasker Awards for their work on the GLP-1 hormone. Others were honored for work to stop H.I.V. and for immune system discoveries. Gina Kolata and Stephanie Nolen | NYTimes Health | Disclosure

An Agonizing Dilemma: When Obesity Prevents a Joint Replacement

Many doctors say it is too dangerous to perform the common surgeries on people with high body mass indexes, but patients say they are facing discrimination. Gina Kolata | NYTimes Health | Disclosure

What’s in Your Fridge? Here Are Details About the Deli Meat Listeria Recall

Seven million pounds of Boar’s Head meats have been recalled since late July, when reports of serious illnesses and deaths began to occur. Teddy Rosenbluth | NYTimes Health | Disclosure

Teenage E-Cigarette Use Drops to a 10-Year Low

The percentage of middle and high school students reporting that they vaped tobacco products declined to about a third of the peak levels in 2019, a new survey shows. Christina Jewett | NYTimes Health | Disclosure

New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

Comments

Post a Comment